Suchergebnisse - "Moreau, Philippe"

PubPharm (1.156)

1

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1

enthalten in: Blood | 2024

von Cortes-Selva, D. | Perova, T. | Skerget, S. | +22

2

Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rodriguez-Otero, P. | Ailawadhi, S. | Arnulf, B. | +19

3

Force propagation between epithelial cells depends on active coupling and mechano-structural polarization

enthalten in: bioRxiv.org | 2024

von Ruppel, A. | Wörthmüller, D. | Misiak, V. | +10

4

Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Mateos, M. | Weisel, K. | Diels, J. | +7

5

An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma

enthalten in: Nature immunology | 2024

von de Jong, M. | Fokkema, C. | Papazian, N. | +17

6

A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics

enthalten in: Blood | 2024

von Durand, R. | Descamps, G. | Bellanger, C. | +17

CommentIn: Blood. 2024 Mar 28;143(13):1202-1204. - PMID 38546638

7

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2024

von Einsele, H. | Moreau, P. | Bahlis, N. | +23

8

Mechanisms of resistance to bispecific T cell engagers in multiple myeloma and their clinical implications

enthalten in: Blood advances | 2024

von Letouzé, E. | Moreau, P. | Munshi, N. | +3

9

An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd) : SELECT study

enthalten in: Leukemia & lymphoma | 2024

von Perrot, A. | Delimpasi, S. | Spanoudakis, E. | +8

10

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[116]